← Leaderboards
Christopher G. Conrad
Biomedisyn Corporation
$246,905
Attributed
$246,905
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$246,905 · 1
By mechanism
R41$246,905 · 1
Top collaborators
No co-investigators on record.
Most similar at Biomedisyn Corporation
Same institution · by research overlap
- Joseph P Steiner$2,955,508
Others in their field
Top investigators on “Acquired Immunodeficiency Syndrome”
- David Heimbrook · Leidos Biomedical Research, Inc.$300,790,583
- George R Seage · Abt Associates, Inc.$244,444,207
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$180,045,219
- Barbara Driver · Westat, Inc.$168,632,670
- Michelle Vargas · Ppd Development Lp$163,846,102
- Judith S. Currier · University Of California Los Angeles$150,146,659
Research focus
Acquired Immunodeficiency SyndromeAdolescentAdultAffectAids Dementia ComplexAids/Hiv ProblemAnimal ModelAnti-Retroviral AgentsAntiviral AgentsArt ProteinBaseBrainCell PhysiologyCellsClinical TrialsCognitionDisabilityDistalDoseDrug DevelopmentDrug KineticsEffective TherapyEnantiomerAcetylcholinesterase Inhibitors